Success Metrics

Clinical Success Rate
86.3%

Based on 297 completed trials

Completion Rate
86%(297/344)
Active Trials
167(23%)
Results Posted
20%(60 trials)
Terminated
47(6%)

Phase Distribution

Ph phase_2
35
5%
Ph phase_3
12
2%
Ph phase_4
13
2%
Ph phase_1
45
6%
Ph early_phase_1
6
1%
Ph not_applicable
298
40%

Phase Distribution

51

Early Stage

35

Mid Stage

25

Late Stage

Phase Distribution409 total trials
Early Phase 1First-in-human
6(1.5%)
Phase 1Safety & dosage
45(11.0%)
Phase 2Efficacy & side effects
35(8.6%)
Phase 3Large-scale testing
12(2.9%)
Phase 4Post-market surveillance
13(3.2%)
N/ANon-phased studies
298(72.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.1%

297 of 366 finished

Non-Completion Rate

18.9%

69 ended early

Currently Active

167

trials recruiting

Total Trials

740

all time

Status Distribution
Active(220)
Completed(297)
Terminated(69)
Other(154)

Detailed Status

Completed297
unknown153
Recruiting134
Not yet recruiting48
Terminated47
Active, not recruiting33

Development Timeline

Analytics

Development Status

Total Trials
740
Active
167
Success Rate
86.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 16 (1.5%)
Phase 145 (11.0%)
Phase 235 (8.6%)
Phase 312 (2.9%)
Phase 413 (3.2%)
N/A298 (72.9%)

Trials by Status

suspended10%
active_not_recruiting334%
completed29740%
terminated476%
withdrawn223%
enrolling_by_invitation51%
not_yet_recruiting486%
unknown15321%
recruiting13418%

Recent Activity

Clinical Trials (740)

Showing 20 of 740 trialsScroll for more
NCT02107989

Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database

Recruiting
NCT02382601

Longitudinal Study of Intra-Uterine Growth Restriction

Recruiting
NCT04309760Not Applicable

Developmental Correlates and Hormone Therapy Effects in Gender Dysphoria

Withdrawn
NCT07630324Not Applicable

MEG and Aphantasia

Not Yet Recruiting
NCT05864794Not Applicable

Value of Screening MRI Brain in Stage IV Non-small Cell Lung Cancer

Recruiting
NCT05331040

Radiomics in Rectal Cancer

Withdrawn
NCT00798122Not Applicable

Study of Women With Acute Coronary Syndromes and Nonobstructive Coronary Artery Disease

Active Not Recruiting
NCT02193425Early Phase 1

Reliability of the Human Brain Connectome

Completed
NCT04586049

Cardiovascular and Neurovascular Regulation in GWI

Active Not Recruiting
NCT05150353Not Applicable

Detection of Amyloid Deposits in the Wrist by MRI With Mapping and High Resolution Sequences in Systemic Amyloidosis (AMYLOCARP)

Completed
NCT06626022Phase 3

Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.

Recruiting
NCT05146492Not Applicable

Pericardial Effusion From Acute Myocardial Infarction: Contributing Factors and Prognosis at One Year (EPERICARDIM)

Terminated
NCT05963113Not Applicable

Pharyngeal Exercise (Plus Protein)

Recruiting
NCT06661720Phase 3

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Recruiting
NCT00001595

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

Recruiting
NCT07616323

Screening LUMBAR Syndrome in Infants With Infantile Hemangiomas

Not Yet Recruiting
NCT05707806

Development and Validation of Learning and Decision-Making Tasks

Recruiting
NCT07612046

A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening

Recruiting
NCT05072483

Natural History Study of CADASIL

Recruiting
NCT07218653Early Phase 1

Human Cerebrovascular Blood Flow and Sex Differences in Metabolic Syndrome

Not Yet Recruiting

Drug Details

Intervention Type
DEVICE
Total Trials
740